Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP3A4/5 and P-glycoprotein activity in renal transplantation
2008-004158-33Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of midazolam and fexofenadine in Kidney allograft status (RTx), sponsored by KU Leuven. Primary endpoints: Effect of genetic and non-genetic factors on midazolam disposition, Effect of genetic and non-genetic factors on fexofenadine disposition and 2 more. Started Sep 2008; status: completed.
02
Drugs
midazolamfexofenadine
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2008-004158-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004158-33.